Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Insuman Rapid 100 IU/ml solution for injection in a cartridge
Medicines register · Ireland

Insuman Rapid 100 IU/ml solution for injection in a cartridge

Authorisation EU/1/97/030/055 · Sanofi-Aventis Deutschland GmbH

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 21 Nov 2026
Licence holder
Sanofi-Aventis Deutschland GmbH (all products →)
Active substance
Insulin human
Dosage form
Solution for injection in cartridge
Routes of administration
Intramuscular use, Subcutaneous use
ATC codes
A10AB, A10AB01
First authorised
18/02/1999
Prescription status
Product subject to prescription which may be renewed (B)
Supply
Supply through pharmacies only
Legal basis
Full application (Article 8(3) of Directive No 2001/83/EC)

Insulin human: supply and approvals

51 authorised products on the HPRA list contain Insulin human. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
Insuman Rapid, Basal and Comb 25 (insulin human): Shortage ongoing, first published 24 Jan 2023
Insuman Basal and Comb 25: Medicine discontinued, first published 1 Dec 2015
Insuman Rapid, Basal and Comb: Shortage resolved, first published 31 Mar 2015
US shortage (FDA)
No entry in the FDA drug shortage list (checked 20 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 20 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 030. It has been authorised for 27 years (since 18 February 1999). The HPRA list does not say whether it is on sale.

Open the European Commission’s Union Register record →

Other medicines with Insulin human in Ireland

50 other products on the HPRA list contain Insulin human, from 2 licence holders; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
ActraphaneNovo Nordisk A/SCentralised EU authorisationNot stated
Actraphane 30 40 IU/ml Suspension for injectionNovo Nordisk A/SCentralised EU authorisationNot stated
Actraphane 30 40 IU/ml Suspension for injectionNovo Nordisk A/SCentralised EU authorisationNot stated
ActrapidNovo Nordisk A/SCentralised EU authorisationNot stated
ActrapidNovo Nordisk A/SCentralised EU authorisationNot stated
InsulatardNovo Nordisk A/SCentralised EU authorisationNot stated
Insulatard 100 international units/ml suspension for injection in vialNovo Nordisk A/SCentralised EU authorisationNot stated
Insulatard FlexPenNovo Nordisk A/SCentralised EU authorisationNot stated
Insulatard InnoLetNovo Nordisk A/SCentralised EU authorisationNot stated
Insulatard PenfillNovo Nordisk A/SCentralised EU authorisationNot stated
Insuman Basal 100 IU/ml suspension for injection in a cartridgeSanofi-Aventis Deutschland GmbHCentralised EU authorisationNot stated
Insuman Basal 100 IU/ml suspension for injection in a cartridgeSanofi-Aventis Deutschland GmbHCentralised EU authorisationNot stated

All 51 products with Insulin human →

Other substances in ATC group A10AB

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 4 other active substances share the group A10AB with this product:

Insulin lispro (12) · Insulin aspart (7) · Insulin glulisine (2) · Human insulin (recombinant dna origin) (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

Sanofi-Aventis Deutschland GmbH holds 56 products on the HPRA list, with 5 different active substances; 0 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.